Abeona Therapeutics Inc. (ABEO)
NASDAQ · Healthcare
Abeona Therapeutics Inc. Operating Income 2010–2025
Abeona Therapeutics Inc. annual/quarterly operating income history and growth rate from 2010 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Abeona Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -23.0 M, a 11.86% increase year-over-year.
- Abeona Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -64.4 M, a 7.85% decrease year-over-year.
- Abeona Therapeutics Inc. annual operating income for 2025 was -89.4 M, a 89.77% increase from 2023.
- Abeona Therapeutics Inc. annual operating income for 2023 was -47.1 M, a 7.42% decrease from 2022.
- Abeona Therapeutics Inc. annual operating income for 2022 was -50.9 M, a 43.32% decrease from 2021.
- Abeona Therapeutics Inc. annual operating income for 2021 was -89.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Abeona Therapeutics Inc. Operating Income — FAQ
Abeona Therapeutics Inc. (ABEO) operating income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Abeona Therapeutics Inc.'s operating income?
Abeona Therapeutics Inc. (ABEO) reported operating income of -$89M for fiscal 2025.
Where can I see ABEO's operating income history?
The chart and table above show Abeona Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.